Serial Number 88319649
Registration 5882928
700

Registration Progress

Application Filed
Feb 28, 2019
Under Examination
Approved for Publication
Jul 30, 2019
Published for Opposition
Jul 30, 2019
Registered
Oct 15, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20191015) (Grace Period Filing)
Due: Apr 15, 2026 Grace Period - 118 days
Original deadline was Oct 15, 2025 (overdue)

Trademark Image

Basic Information

Serial Number
88319649
Registration Number
5882928
Filing Date
February 28, 2019
Registration Date
October 15, 2019
Published for Opposition
July 30, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 15, 2019
Registration
Registered
Classes
042

Rights Holder

Amylyx Pharmaceuticals, Inc.

03
Address
43 Thorndike Street
Cambridge, MA 02141

Ownership History

Amylyx Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Amylyx Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Amylyx Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Cynthia Johnson Walden

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20191015)
Due Date
October 15, 2025
Grace Period Ends
April 15, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description Documents
Sep 29, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 15, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 15, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 30, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 30, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 25, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 10, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 21, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 19, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 19, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 13, 2019 ALIE A ASSIGNED TO LIE Loading...
Jun 7, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 17, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 17, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 17, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 9, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 19, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 4, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; pharmaceutical drug development services; testing of pharmaceuticals
First Use Anywhere: Jan 8, 2014
First Use in Commerce: Jan 8, 2014

Additional Information

Design Mark
The mark consists of a flame and a torch base.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042